loader
Please Wait
Applying Filters...

Seqens Seqens

X

Information, Expiry & Status of Health Canada Patents covering Bevacizumab.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Gowling Lafleur Henderson LLP (2)

02 Gowling WLG (Canada) LLP (1)

filter

01 2145985 (1)

02 2286330 (1)

03 2787952 (1)

filter

01 Bevacizumab (3)

filter

01 Concentrate for Solution for Infusion (3)

filter

01 2012-10-28 (1)

02 2018-03-04 (1)

03 2031-02-22 (1)

Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2286330
25mg / ml
Concentrate for Solution for Infusion
Human
2018-03-04
2008-10-06
1998-03-04
AVASTIN
Intravenous
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2145985
25mg / ml
Concentrate for Solution for Infusion
Human
2012-10-28
2003-09-16
1992-10-28
AVASTIN
Intravenous
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2787952
25mg / ml
Concentrate for Solution for Infusion
Human
2031-02-22
2016-07-26
2011-02-22
AVASTIN
Intravenous
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY